Lipella Pharmaceuticals effects 1-for-8 reverse stock split

LIPELLA PHARMACEUTICALS INC.

Reverse split effective Nov 7, 2024; every 8 shares converted to 1 share.
No fractional shares issued; holders paid cash for fractional interests.
Authorized share count unchanged; options and warrants adjusted proportionally.
Common stock trades split-adjusted on Nasdaq Capital Market starting Nov 8.
New CUSIP number for common stock is 53630L 209.

item 3.03 item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

LIPELLA PHARMACEUTICALS INC.: effected a one-for-eight reverse stock split of common stock (effective 2024-11-07).

Change: charter amendment
Effective: 2024-11-07

Exact text from the filing

On November 7, 2024, Lipella Pharmaceuticals Inc. (the “Company”), acting pursuant to authority received at an annual meeting of its stockholders on September 10, 2024, filed with the Secretary of State of the State of Delaware a certificate of amendment (the “Charter Amendment”) to its second amended and restated certificate of incorporation, as amended (the “Certificate of Incorporation”), which effected a one-for-eight reverse stock split (the “Reverse Stock Split”) of all of the Company’s outstanding shares of common stock, par value $0.0001 per share (the “Common Stock”).

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

LIPELLA PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR

accession 0001753926-24-001824

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.